Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 27, 2018
Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical TrialsWilliam J Sandborn, Julián Panés, Geert R D'Haens, et al.
Inflammatory Bowel Diseases|September 2, 2020
Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient ManagementBruce E Sands, Jean-Frédéric Colombel, Christina Ha, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2020
Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative ColitisJean-Frederic Colombel, Mark T Osterman, Andrew J Thorpe, et al.
Inflammatory Bowel Diseases|March 20, 2021
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical ProgramBruce E Sands, Millie D Long, Walter Reinisch, et al.
Journal of Crohn'S & Colitis|November 27, 2020
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical ProgrammeKevin L Winthrop, Edward V Loftus, Daniel C Baumgart, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2018
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative ColitisStephen Hanauer, Remo Panaccione, Silvio Danese, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 12, 2019
Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative ColitisBruce E Sands, Pam R Taub, Alessandro Armuzzi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 12, 2024
Qualified kidney injury biomarkers demonstrate value during early clinical drug developmentKodihalli C Ravindra, Kelly A Fader, David Potter, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 25, 2020
Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting reportRoslyn B Mannon, Randall E Morris, Michael Abecassis, et al.
Pageof 2